In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Galit Akerman-SánchezDepartment of Physiology, School of Medicine, University of Costa Rica, San José 11501, Costa Rica.ORCID 0000-0002-2837-6566 Steve PeigneurToxicology and Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven (KU Leuven), 3000 Leuven, Belgium.ORCID 0000-0003-0504-5702 Kathleen CarleerToxicology and Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven (KU Leuven), 3000 Leuven, Belgium.
Natalia OrtizDepartment of Biochemistry, School of Medicine, University of Costa Rica, San José 11501, Costa Rica.ORCID 0000-0003-1866-473X Felipe NaviaLaboratory of Herpetology and Toxinology, University of the Valley, Cali 760043, Colombia.ORCID 0000-0003-2943-7102 Leonardo FierroLaboratory of Herpetology and Toxinology, University of the Valley, Cali 760043, Colombia.
Santiago CastañoLaboratory of Herpetology and Toxinology, University of the Valley, Cali 760043, Colombia.ORCID 0000-0003-2758-8994 Cecilia DíazDepartment of Biochemistry, School of Medicine, University of Costa Rica, San José 11501, Costa Rica.ORCID 0000-0001-7403-9336 Jan TytgatToxicology and Pharmacology, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven (KU Leuven), 3000 Leuven, Belgium.ORCID 0000-0003-1778-6022 Oscar BrenesDepartment of Physiology, School of Medicine, University of Costa Rica, San José 11501, Costa Rica.ORCID 0000-0003-3830-9364 Funding
FWO-Vlaanderen 12W7822NUniversidad de Costa Rica C0-608
6 · The paper itselfAbstract
Scorpion neurotoxins are small peptides that target ion channels and offer opportunities for novel therapeutic discovery. This study analyzed the functional effects of the venom and toxins from the Costa Rican endemic scorpion,
Indexed as
PainScorpionsScorpion VenomsVoltage-Gated Sodium ChannelsAction PotentialsAnimalsHumansModels, MolecularNAV1.6 Voltage-Gated Sodium ChannelNAV1.7 Voltage-Gated Sodium ChannelNeuronsNAV1.6 Voltage-Gated Sodium ChannelNAV1.7 Voltage-Gated Sodium ChannelScorpion VenomsVoltage-Gated Sodium ChannelsbuthidaeCornuelectrophysiologyHelixinvertebrate neuronsmolecular dockingoocytesscorpion venomTityusvoltage-gated sodium channelsXenopus
Identifiers
PMID42072673
PMCPMC13113398
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390